Found 8 matching trials
Dual IntraVenous Thrombolysis Approach (DIVA) in Patients With Medium-vessel-occlusion Strokes: a Retrospective Study N/A The purpose of this study (Dual IV thrombolysis Approach (DIVA) study) is t...
Show More Location
Centre Hospitalier Sud Francilien
Learn More & Join Trial
Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion PHASE3 The purpose of this study is to investigate the safety and efficacy of endo...
Show More Location
The First Affiliated Hospital of USTC
Learn More & Join Trial
Tirofiban Plus Intravenous Thrombolysis in Acute Anterior Choroidal Infarction or Paramedian Pontine Infarction N/A TITACIPPI (Tirofiban with Intravenous Thrombolysis in Acute Anterior Choroi...
Show More Location
Centre Hospitalier Sud Francilien
Learn More & Join Trial
Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke PHASE2 STARS is a prospective, multicentre, open-label, dose escalation, Phase IIa...
Show More Location
Royal Prince Alfred Hospital
Learn More & Join Trial
Thrombolysis in Factor Xa-inhibitors Trial PHASE3 This study looks at whether stroke patients who take FXa inhibitors (a type...
Show More Location
Dept. of Medicine, Baerum Hospital
Learn More & Join Trial
Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake PHASE4 DO-IT is an international, multicenter, prospective, two-arm, randomized, o...
Show More Location
Barmherzige Brüder Krankenhaus Eisenstadt
Learn More & Join Trial
ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 PHASE3 This domain has a prospective, randomized, controlled, open-label, parallel...
Show More Location
The George Institute for Global Health
Learn More & Join Trial
Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC NA Direct oral anticoagulants (DOAC) have emerged as safe and efficacious isch...
Show More Location
Chinese University of Hong Kong
Learn More & Join Trial